Pharmacotherapy for major depression with melancholic features: Relative efficacy of tricyclic versus selective serotonin reuptake inhibitor antidepressants

Journal of Affective Disorders

Volumn 39, Issue 1, 1996, Pages 1-6

  Perry, Paul J ^a,b  

^a UNIVERSITY OF IOWA   (United States)

^b UNIVERSITY OF IOWA   (United States)

Author keywords

Endogenous depression; Melancholia; Selective serotonin reuptake inhibitor; Tricyclic antidepressant

Indexed keywords

AMITRIPTYLINE; CITALOPRAM; CLOMIPRAMINE; DESIPRAMINE; FLUOXETINE; IMIPRAMINE; LITHIUM; NORTRIPTYLINE; PAROXETINE; PERPHENAZINE; SEROTONIN UPTAKE INHIBITOR; TRICYCLIC ANTIDEPRESSANT AGENT;

CLINICAL FEATURE; DEPRESSION; DRUG EFFICACY; HUMAN; MELANCHOLIA; PRIORITY JOURNAL; PSYCHOPHARMACOTHERAPY; REVIEW;

EID: 0030594646     PISSN: 01650327     EISSN: None     Source Type: Journal    
DOI: 10.1016/0165-0327(96)00014-6     Document Type: Review

References (22)

1. American Psychiatric Association (1980) DSM-III Diagnostic and Statistical Manual of Mental Disorders, 3rd Edn. APA, Washington, DC.
2. Beasley, C.M., Holman, S.L. and Potvin, J.H. (1993) Fluoxetine compared with imipramine in the treatment of inpatient depression. Ann. Clin. Psychiatry 5, 199-207.
3. Bowden, C.L., Schatzberg, A.F., Rosenbaum, A., Contreras, S.A., Samson J.A., Dessain E. and Sayler, M. (1993) Fluoxetine and desipramine in major depressive disorder. J. Clin. Psychopharmacol. 13, 305-310.
4. Danish University Antidepressant Group (1986) Citalopram: clinical effect profile in comparison with clomipramine: a controlled multicenter study. Psychopharmacology (Berl.) 90, 131-138.
5. Danish University Antidepressant Group (1990) Paroxetine: a selective serotonin reuptake inhibitor showing better tolerance, but weaker antidepressant effect than clomipramine in a controlled multicenter study. J. Affect. Disord. 18, 289-299.
6. Heiligenstein, J.H., Tollefson, G.D. and Faries, D.E. (1994) Response patterns of depressed outpatients with and without melancholia: a double-blind, placebo-controlled trial of fluoxetine versus placebo. J. Affect. Disord. 30, 163-173.
7. Laakman, G., Blaschke, D., Engel R. and Schwarz, A. (1988) Fluoxetine vs amitriptyline in the treatment of depressed outpatients. Br. J. Psychiatry 153 (Suppl. 3), 64-68.
8. Nelson, D.R., Thomas, D.R. and Johnson, A.M. (1989) Pharmacological effects of paroxetine after repeated administration to animals. Acta Psychiatr. Scand. 80: (Suppl. 35), 21-23.
9. Nelson, J.C., Mazure, C.M., Bowers, M.B. and Jatlow, P.I. (1991) A preliminary, open study of the combination of fluoxetine and desipramine for rapid treatment of depression. Arch. Gen. Psychiatry 48: 303-307.
10. Pursel, M. and Perry, P. (1995) Fiscal year 1994-1995 annual report of drug ranking by prescription number. Iowa Medicaid Drug Utilization Review Commission, Des Moines, Iowa.
11. Quitkin, F.M., Harrison, W., Liebowitz, M., McGrath, P., Rabkin, J.G., Stewart, J. and Markowitz, J. (1984) Defining the boundaries of atypical depression. J. Clin. Psychiatry 45(7 Pt. 2), 19-21.
12. Reimherr, F.W., Wood, D.R., Byerley, B., Brainard, J. and Grosser, B.I. (1984) Characteristics of responders to fluoxetine. Psychopharmcol. Bull. 20, 70-72.
13. Roose, S.P., Glassman, A.H., Attia, E. and Woodring, S. (1994) Comparative efficacy of selective serotonin reuptake inhibitors and tricyclics in the treatment of melancholia. Am. J. Psychiatry 151, 1735-1739.
14. Rothschild, A.J., Samson, J.A., Besserte, M.P. and Carter-Campbell, J.T. (1993) Efficacy of the combination of fluoxetine and perphenazine in the treatment of psychotic depression. J. Clin. Psychiatry 54, 338-342.
15. Spiker, D.G., Weiss, J.C., Dealy, R.S., Griffin, S.J., Hanin, I., Neil, JF. Perel, JM. Rossi, AJ. and Soloff, PH. (1985) The pharmacological treatment of delusional depression. Am. J. Psychiatry 142, 430-436.
16. Spiker, D.G., Dealy, R.S., Hanin, I., Weiss J.C. and Kupfer, D.J. (1986) Treating delusional depressives with amitriptyline. J. Clin. Psychiatry 47, 243-246.
17. Spitzer, R.L., Endicott, J. and Robins, E. (1978) Research Diagnostic Criteria. New York State Psychiatric Institute, New York.
18. Stuppaeck, C.H., Geretsegger, C., Whitworth, A.B., Schubert, H., Platz, T., Konig, P., Hinterhuber, H. and Felischhacer, W.W. (1994) A multicenter double-blind trial of paroxetine versus amitriptyline in depressed inpatients. J. Clin. Psychopharmacol. 14, 241-246.
19. Tignol, J., Stoker, M.J. and Dunbar, G.C. (1992) Paroxetine in the treatment of melancholia and severe depression. Int. Clin. Psychopharmacol. 7, 91-94.
20. Tollefson, G.D. and Holman, S.L. (1993) Analysis of the Hamiltion Depression Rating Scale factors from a double-blind, placebo-controlled trial of fluoxetine in geriatric major depression. Int. Clin. Psychopharmacol. 8, 253-259.
21. Winokur, G. (1991) Mania and Depression, A Classification of Syndrome and Disease. Baltimore: Johns Hopkins University Press.
22. Zimmerman, M., Stangl, D., Pfohl, B. and Coryell, W., (1984) Diagnosing RDC endogenous depression and DSM-III melancholia [letter]. Psychiatry Res. 12, 173-176.